Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
The Christie NHS Foundation Trust
OBJECTIVES:
* Determine early in the course of treatment which patients treated on clinical trial CRUK-VORTEX have an increased likelihood of distant metastases so as to highlight individuals who might benefit from early adjuvant systemic therapy.
OUTLINE: This is a multicenter study.
Tumour and normal tissue samples will be taken at the time of surgery during treatment on clinical trial CRUK-VORTEXand preserved for future microarray analyses. Tissue microarrays will be produced from both tumor and normal tissues. Blood samples will be collected for future DNA analysis.
Age
16–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
DISEASE CHARACTERISTICS:
Histologically confirmed soft tissue sarcoma
Receiving treatment on clinical trial CRUK-VORTEX
Underwent surgery to remove the tumor no more than 3 months ago
PATIENT CHARACTERISTICS:
Not pregnant or nursing
Negative pregnancy test
Fertile patients must use effective contraception during and for 3 months after completion of study treatment
No other major medical illness that would preclude study treatment
No other prior or concurrent malignancy except adequately treated nonmelanoma carcinoma of the skin or in situ carcinoma of the cervix